Major interference by Disulphine Blue in the colorimetric determination of amylase, albumin, protein, iron and total iron-binding capacity is described. The drug, an intense blue dye, was administered intravenously to a patient before surgery to allow demarcation of devitalised bone. Successive sampling showed the drug to have a half-life of 30 hours, to remain visible for 150 hours in both urine and blood, and to cause significant interference with the five analytes for up to 2i days.
SUMMARY Major interference by Disulphine Blue in the colorimetric determination of amylase, albumin, protein, iron and total iron-binding capacity is described. The drug, an intense blue dye, was administered intravenously to a patient before surgery to allow demarcation of devitalised bone. Successive sampling showed the drug to have a half-life of 30 hours, to remain visible for 150 hours in both urine and blood, and to cause significant interference with the five analytes for up to 2i days.
The 640 nm absorbance peak of Disulphine Blue was shown to be pH-dependent, and therefore the reaction conditions of individual methods may influence the degree of interference.
no clinical or biochemical evidence of impaired renal or hepatic function. Urine and blood samples were collected at intervals over seven days after injection, and the dye's absorption peak of 640 nm was monitored to determine its rate of clearance from the blood.
Twenty-five commonly measured analytes were screened for potential interference from the dye by treating pooled human plasma with sufficient Disulphine Blue to achieve the same absorbance as is present 2! hours after administration of the dye to a patient.
To relate the degree of interference to the time of blood sampling after dye injection, a dose-response relationship between dye absorbance and apparent analyte concentration was obtained for the five constituents shown to be subject to interference. The dose response curve was then related to the decay curve obtained earlier, and from it the time interval required to ensure insignificant interference was derived.
The analytical methods used in the study were as follows:
Method
Total protein by a discrete version of an end-point biuret reaction." Amylase using the Phadebas Cibachron blue starchcomplex reaction. Albumin by a discrete version of a bromocresol purple reaction," Iron by a continuous-flow method using ferrozine as A 64-year-old 89 kg man was injected intravenously the chromogen (Technicon sheet AAl-25). with 30 ml Disulphine Blue before surgery to the left TIBC as above, using magnesium carbonate to femur. The patient was otherwise in good health with absorb free iron (Technicon sheet AAll-2S). 317
We report the interference effects of tlie drug Disulphine Blue on routine colorimetric biochemical investigations. Disu1phine Blue, available from Imperial Chemical Industries is the monosodium salt of anhydro-4 :4'-bis-diethylarrino triphenyl rr.ethanol-2':4'-disulphonic acid (Sulphan Blue) and has the property of staining vital tissues perfused by the vascular bed. The drug was first used by Sorsby in 1939 for the evaluation of retinal detachment.' It has since found applications in plastic surgery, assessing tissue viability following burns.s soft tissue trauma.P and skin grafts." and for outlining the lymphatic system before lymphangiography." Its value in the demarcation of devitalised bone tissue at operation has recently been described" 7 and was the reason for its use in this study. The potential interference of this drug with colorimetric biochemical investigations was identified after a request for emergency 'on-call' tests on an unusually coloured blood sample. Manufacturers' literature and a recent paper describing the use of Disulphine Blue" clearly, but erroneously, state that 'the accuracy of routine laboratory techniques which rely on colorimetric methods is not impaired'. We describe those parameters in which we have found interference, the extent of the interference, and the period of time after drug administration that needs to lapse before it is no longer significant.
Total bilirubin by a discrete method using sulphanilic acid and a caffeine-benzoate accelerator. Bicarbonate by a continuous-flow cresol-red reaction (Technicon sheet AAII--08). Calcium by a continuous-flow cresolphthalein cornplexone method (Technicon sheet AAII--03). Cholesterol by a discrete cholesterol oxidase end point method (Boehringer Mannheim C-system Cat. No. 237 574). Creatinine by a discrete kinetic alkaline-picrate reaction (Boehringer Mannheim Cat. No. 124192) . Glucose by a continuous-flow glucose-oxidase/4aminophenazone method (Technicon AAI1-Glucinet (GOD-POD) reaction). Magnesium by a manual method described by Mann and Yoe.l? Phosphate by a continuous-flow phosphomolybdate/ stannous chloride-hydrazine method (Technicon sheet AAII--04). Triglyceride by a kinetic lipase/glycerol kinase method (Boehringer Mannheim Cat. No. 244 473) . Urea by a continuous-flow diacetyl-rnonoxime method (Technicon sheet AAII--Ol). Uric acid by a continueus-flow phosphotungstate reduction method (Technicon sheet . Acid phosphatase using p-nitrophenylphosphate as substrate (Boehringer Mannheim Cat. No. 125008) . ALT, AST, and LDH by the recommended Scandinavian method (Boehringer Mannheim Cat. Nos 191345,191 337 and 191353 
Results
Disulphine Blue was shown to have an absorption peak at 640 nm, which was pH dependent between pH 1· 0 and 3·2. At the pH encountered in the fresh blood and urine samples, the absorption of the dye was not subject to change. A linear Beer's law relationship was demonstrated throughout the absorption range used in this work. This observation enables absorption measurements to be used reliably for monitoring the clearance of the drug from the blood.
Halloran and Torrens
The clearance characteristics of the dye in the patient monitored is shown in the Figure 1 . The biphasic linear relationship corresponds to the drug's initial period of distribution throughout the body's fluid compartments followed by its elimination in the urine. The latter phase indicates the dye's half-life to be 30 hours in the patient studied.
Interference by the dye was demonstrated in five of the analytes examined, albumin, total protein, amylase, iron, and iron-binding capacity. Table I shows the data obtained from the pooled sample for aliquots both treated and untreated with Disulphine Blue. The absorbance of the treated sample corresponded to a blood sample taken approximately 2! hours after the administration of the drug. Significant differences between the mean values of each treated and untreated pool were demonstrated by a t test.
The dose-response relationship was obtained by adding diminishing aliquots of Disulphine Blue to a further serum pool and assaying each for the five analytes subject to interference. In Table 2 , the various analyte concentrations are related to the 640 nm absorbance of each treated sample, and using the clearance curve in the Figure are also related to a corresponding time after drug administration. Extrapolation between the individual times suggests that amylase would be subject to minimal interference after 60 hours, albumin, iron, and total iron-binding capacity after 30 hours, and total protein after 25 hours. 
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Discussion
Methodological and physiological drug interference with biochemical analyte concentrations are well recognised but frequently ignored phenomena. Useful drug interference data which relate drug dose, blood levels, and time after administration to the degree of interference in unambiguously defined assay methods are not readily available. Disulphine Blue has been described as devoid of interfering properties and also subject to clearance by the kidney in about 48 hours. This study was unable to support these reports. It provides the first description of the clearance characteristics of the dye from the blood and shows it to have a half-life of 30 hours. Visible evidence of the presence of Disulphine Blue in both blood and urine was seen 150 hours after its administration. The patient used for the clearance study was typical of those to whom the dye might be administered; he had no evidence of renal or hepatic dysfunction and was subjected to surgery immediately after administration of the drug. Interference with albumin, amylase, total protein, iron. and iron-binding capacity was substantial during the first 20 hours after the dose, with complete absence of interference only after 2 to 2t days. These methods had measurement wavelengths at 610, 620, 563, 560, and 560 nm, respectively, consistent with the maximum absorbance of Disulphine Blue at 640 nm.
The pH dependence of the 640 nm absorption peak of Disulphine Blue is such that the interference is reduced when reaction conditions are at a pH lower than pH 3·2. This effect did not apply to the methods used in this laboratory for the determination of those five analytes subject to interference.
In conclusion, blood taken up to 2-2t days after intravenous injection of Disulphine Blue will be unsuitable for determination of albumin, total protein, amylase, iron, and total iron-binding capacity. A preliminary report of this study has been published.P
